Orano SA (Orano) is a company engaged in the nuclear fuel cycle, providing expertise in the design, approval, and manufacturing of casks, and conducting transport operations. It operates across the entire nuclear fuel cycle, including mining, conversion, enrichment, recycling, and dismantling services. Orano operates manufacturing centers and uranium production sites in Canada and Kazakhstan, with additional projects in Mongolia and Namibia. The company has a diversified portfolio of assets and resources, ensuring long-term security of uranium supplies. It conducts exploration projects in the Athabasca basin and holds equity interests in several deposits.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Orano's R&D is focused on improving mining techniques, optimizing conversion plant operations, enhancing reprocessing-recycling sustainability, developing new shipping casks for nuclear materials, supporting decommissioning operations, recycling critical materials from lithium batteries, and developing radionuclides for medical applications. The company also emphasized the development of molten salt reactors for recycling plutonium and minor actinides, and the preservation of resources and health through low-carbon activities. The R&D units of Orano are responsible for supporting the company's long-term commercial and technological positioning, ensuring compliance with applicable regulations, and focusing on areas with high development potential. The units work on nuclear and medical R&D projects and the recovery of strategic metals, with around 70% of efforts directed towards low-carbon activities or products. The company filed 26 first patent applications in 2025. Orano collaborates with an ecosystem of players in France and abroad to develop new nuclear reactor concepts, such as Small Modular Reactors (SMR), Advanced Modular Reactors (AMR), and Molten Salt Reactors (MSR). In FY2025, the company spent EUR212 million on its R&D activities, which as a percentage of revenue accounted for 4.1% of the revenue.